Vedolizumab treatment within 4 weeks of ileocolonic resection outperformed placebo in preventing postoperative endoscopic recurrence of Crohn’s disease in patients with at least one risk factor for ...
Several factors can influence a person’s life expectancy if they experience recurrence of pancreatic cancer, including the location of recurrence, a person’s treatment, and their tumor grading, size, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results